Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer. (nejm.org)

Authors: Tolaney SM … Loibl S Journal: New England Journal of Medicine Published: 2026-02-05 DOI: https://doi.org/10.1056/NEJMoa2508668